Frequency and Prognostic Value of KRAS, NRAS, and BRAF Mutations in Metastatic Colorectal Cancer: An Iranian Cohort Study

Abbas Eshraghi, Mohammad Sadegh Ghasemi, Jamshid Vafaeimanesh, Mohammad Sina Mirjani, Mostafa Vahedian, Mohammad Reza Ahmadi · 2026

Read Frequency and Prognostic Value of KRAS, NRAS, and BRAF Mutations in Metastatic Colorectal Cancer: An Iranian Cohort Study by Abbas Eshraghi, Mohammad Sadegh Ghasemi, Jamshid Vafaeimanesh, Mohammad Sina Mirjani, Mostafa Vahedian, Mohammad Reza Ahmadi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13680741.txt.

Description

Abbas Eshraghi and co-authors measured three gene mutation rates in advanced colon cancer patients in Iran in a 2026 study. Mutations in the KRAS, NRAS, and BRAF genes shape prognosis and drug choice in this cancer. The team reviewed eighty-three patients with spread disease at one hospital clinic in Qom and checked one-year survival.

KRAS mutations appeared in forty-seven percent of patients, NRAS in about fourteen percent, and BRAF in six percent. BRAF mutations clustered in patients diagnosed under fifty, a link the statistics supported. No mutation tied clearly to sex, tumor site, spread pattern, or one-year survival in this group. The authors note the small cohort limits firm claims and call for larger national studies.

Catalog record

CREATORAbbas Eshraghi, Mohammad Sadegh Ghasemi, Jamshid Vafaeimanesh, Mohammad Sina Mirjani, Mostafa Vahedian, Mohammad Reza Ahmadi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE25 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13680741

Browse the full library · About the Tower of Babel